The Rohatyn Group Completes Sale of 36.6% Huvepharma Stake To Advance Properties

NEW YORK--(BUSINESS WIRE)--The Rohatyn Group (“TRG”), an independent investment firm focused on emerging markets, today announced that TRG Growth Fund II has finalised the sale of its 36.6% shareholding in Huvepharma AD to Advance Properties OOD, a company controlled by the Domuschiev family. Huvepharma AD, headquartered in Sofia, Bulgaria, is a global fully integrated pharmaceutical company focused on developing, manufacturing and marketing animal health and nutrition products, as well as several key ingredients used in human health products. As a result of this transaction, Advance Properties OOD effectively controls 100% of Huvepharma AD.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC